Skip to main content
. 2020 Mar 11;9(3):207. doi: 10.3390/pathogens9030207

Table 2.

Malaria outcomes at delivery and during pregnancy.

Method n Proportion in % (95% of CI)
Placental tissue Histology (parasites or pigments) 39/417 9.4 (6.9, 12.6)
Placental blood RDT 11/417 2.6 (1.4, 4.7)
microscopy 10/417 2.4 (1.3, 4.4)
PCR 38/417 9.1 (6.5, 12.3)
RDT, microscopy or PCR 38/417 9.1 (6.5, 12.3)
Cord blood RDT 11/417 2.6 (1.4, 4.7)
microscopy 10/417 2.4 (1.3, 4.4)
PCR 21/417 5 (3.3, 7.6)
RDT, microscopy or PCR 22/417 5.3 (3.3, 7.9)
Maternal blood at delivery RDT 12/417 2.9 (1.6, 5.0)
microscopy 9/417 2.2 (1.1, 4.1)
PCR 41/417 9.8 (7.3, 13.1)
RDT microscopy or PCR 42/417 10.1 (7.4, 13.4)
Infection during pregnancy Symptomatic malaria 14/500 2.8 (1.5, 4.7)
Positive RDT at ANC visits 40/500 8 (5.8, 10.7)
Positive RDT and/or PCR at ANC visits 80/500 16 (12.9, 19.5)